Tech Company Financing Transactions
Notch Therapeutics Funding Round
Notch Therapeutics closed a $85 million Series A financing round on 2/17/2021. Investors included Allogene Therapeutics, Amplitude Ventures and Casdin Capital.
Transaction Overview
Company Name
Announced On
2/17/2021
Transaction Type
Venture Equity
Amount
$85,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds for the continuing development of its portfolio of iPSC-derived T cell therapeutic product candidates and clinical readiness of the company's proprietary Engineered Thymic Niche (ETN) platform, to expand its team to support future growth, including establishing operations in Seattle, in addition to the company's existing operations in Vancouver and Toronto.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
40 King St. West 2100
Toronto ON, M5H 3C2
Canada
Toronto ON, M5H 3C2
Canada
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Notch is developing renewable, stem cell-derived immunotherapies, with an initial focus on cancer. We believe that cell therapies can bring value to patients and healthcare systems by being safe, effective, and accessible.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Main
Chief Financial Officer
Kamran Alam
Chief Scientific Officer
Peter Zandstra
Controller
Zain Qureshi
Vice President
Chris Bond
Vice President
Emily Titus
VP - Bus. Development
Gregory Block
VP - Engineering
Steven Woodside
VP - Finance
Bernard Lam
VP - Manufacturing
Elizabeth Csaszar
VP - Operations
Timothy Key
VP - R & D
Shreya Shukla
Browse more venture capital transactions:
Prev: 2/17/2021: Super73 venture capital transaction
Next: 2/17/2021: Metropolis Technologies venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs